Well-being and enhancement: reassessing the welfarist account
Anna Hirsch

TL;DR
This paper examines the welfarist approach to enhancement ethics, arguing it needs a clearer understanding of well-being to be effective.
Contribution
The paper critiques the welfarist account of enhancement and suggests a more nuanced view of well-being is necessary.
Findings
The welfarist account fails to adequately define well-being and is too normative.
Refocusing on well-being can help assess the ethics of biomedical interventions.
A more differentiated understanding of well-being is needed for the welfarist approach to be effective.
Abstract
There are an increasing number of ways to enhance human abilities, characteristics, and performance. In recent years, the ethical debate on enhancement has focused mainly on the ethical evaluation of new enhancement technologies. Yet, the search for an adequate and shared understanding of enhancement has always remained an important part of the debate. It was initially undertaken with the intention of defining the ethical boundaries of enhancement, often by attempting to distinguish enhancements from medical treatments. One of the more recent approaches comes from Julian Savulescu, Anders Sandberg, and Guy Kahane. With their welfarist account, they define enhancement in terms of its contribution to individual well-being: as any state of a person that increases the chances of living a good life in the given set of circumstances. The account aims to contribute both to a shared and clear…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNeuroethics, Human Enhancement, Biomedical Innovations · Mental Health and Psychiatry
